Compared with parental cells or vector-transfected control cells, cells transfected with ECM1b or ECM1a exhibited reduced or enhanced phosphorylated AKT/FAK/Paxillin/Myosin protein levels and xenograft tumor development, respectively (Fig. 4i and Supplementary Fig. 8i, j). The gene discussed is PXN; the disease is neoplasm.